semin
studi
rosen
et
al
design
region
immedi
terminu
human
immunodefici
viru
type
rna
genom
transact
respons
tar
element
cisact
motif
conjunct
viral
transactiv
transcript
tat
protein
significantli
enhanc
transcript
genom
via
modif
transcript
complex
karn
peterlin
price
shortli
thereaft
second
hiv
accessori
protein
regul
express
virion
protein
rev
whose
interact
anoth
cisact
rna
rev
respons
element
rre
regul
nucleocytoplasm
export
fulllength
singlyspl
viral
rna
report
feinberg
et
al
surprisingli
year
crucial
contribut
tattar
revrr
axe
replic
demonstr
rna
viral
host
protein
interact
result
nucleoprotein
complex
proven
therapeut
access
base
primarili
lack
select
small
molecul
ineffici
deliveri
larger
therapeut
oligonucleotid
discoveri
numer
new
class
rna
function
varieti
biolog
process
revolution
molecular
biolog
undoubtedli
profound
implic
clinic
scienc
applic
macromolecul
therapeut
field
still
fledgl
stage
exemplifi
spliceswitch
oligonucleotid
sso
altern
splice
enabl
singl
premesseng
rna
support
multipl
protein
isoform
therebi
increas
divers
proteom
essenti
normal
develop
aberr
splice
underli
signific
number
human
diseas
method
manipul
altern
splice
could
thu
signific
therapeut
valu
exampl
modifi
antisens
oligonucleotid
redirect
splice
site
select
bclx
premrna
bclxl
xs
demonstr
induc
apoptosi
breast
prostat
cancer
cell
second
nanoparticledeliv
sso
reduc
tumor
load
lung
metastas
bauman
et
al
steric
block
oligonucleotid
myoton
dystrophi
character
expans
triplet
repeat
mrna
typic
cag
cug
copi
healthi
individu
mani
diseas
state
myotonia
expand
cug
repeatcontain
transcript
bind
sequest
splice
factor
muscleblindlik
protein
render
unavail
splice
sever
premrna
includ
chlorid
channel
protein
result
muscl
hyperexcit
lee
cooper
mous
model
wheeler
et
al
demonstr
inject
phosphorodiamid
morpholino
oligonucleotid
pmo
complementari
cug
repeat
displac
muscleblindlik
protein
correct
premrna
splice
result
restor
transmembran
chlorid
channel
conduct
mark
reduct
myotonia
extern
guid
sequenc
eg
oligonucleotid
eg
oligonucleotid
design
bind
mrna
target
assum
structur
recogn
degrad
rnase
p
ubiquit
endonucleas
matur
termini
trna
therebi
impair
translat
jiang
et
al
use
eg
strategi
block
human
cytomegaloviru
hcmv
gene
express
target
viral
proteasespecifi
mrna
degrad
jiang
et
al
clinic
implic
eg
compris
pmo
backbon
suggest
effect
antibioticresist
gram
neg
bacteria
wesolowski
et
al
rna
interact
polynucleotid
riptid
microarray
allow
multipl
candid
ligand
sequenc
evalu
parallel
provid
invalu
platform
oligonucleotidebas
rna
target
earli
studi
small
librari
combin
ribonucleotid
lock
nucleic
acid
kierzek
supersed
develop
riptid
array
bear
four
natur
nucleobas
vari
length
gude
et
al
provid
almost
individu
probe
riptid
approach
success
use
identifi
oligonucleotid
inhibit
human
telomeras
function
vitro
cultur
cell
gude
et
al
translat
suppress
oligonucleotid
tso
pmo
describ
repres
class
ribonucleotid
recogn
host
rnasesh
rnainduc
silenc
complex
thu
promot
target
degrad
attribut
exploit
tso
bind
near
initi
codon
consequ
antagon
ribosom
bind
translat
target
protein
detail
descript
approach
found
excel
review
rna
therapeut
kole
et
al
burnett
rossi
knowledg
accumul
last
three
decad
regulatori
rna
motif
would
therefor
expect
creat
new
modal
therapeut
intervent
compris
small
molecul
polypeptid
inhibitori
rna
possibl
combin
thereof
exampl
genom
target
briefli
review
follow
section
understand
hiv
strand
rna
genom
organ
progress
multipl
regulatori
element
dispers
throughout
viral
genom
fig
identifi
subject
extens
examin
consid
therapeut
access
primer
bind
site
pb
complementar
sequenc
preced
uniqu
region
termin
nucleotid
trna
replic
primer
case
mediat
primer
bind
therebi
defin
initi
site
strand
rnadepend
dna
synthesi
abbink
berkhout
le
grice
primer
activ
signal
pa
locat
upstream
pb
interact
pa
antipa
nucleotid
trna
primer
shown
play
import
role
regul
trnaprim
initi
revers
transcript
beeren
et
al
huthoff
et
al
dimer
initi
site
di
togeth
dimer
linkag
sequenc
dl
di
promot
dimer
viral
rna
genom
prior
packag
laughrea
jett
skripkin
et
al
packag
signal
interact
gagencod
nucleocapsid
protein
nc
critic
incorpor
dimer
rna
genom
assembl
virion
l
hernault
et
al
lever
major
splice
donor
site
msd
use
gener
subgenom
splice
transcript
abbink
berkhout
gagpol
frameshift
site
heptanucleotid
slipperi
sequenc
combin
adjac
rna
hairpin
promot
ribosom
frameshift
event
requir
lowfrequ
translat
gagpol
polyprotein
brakiergingra
et
al
polypurin
tract
ppt
locat
center
cppt
region
genom
ppt
allpurin
ribonucleotid
tract
context
rnadna
replic
intermedi
resist
revers
transcriptas
rt
associ
ribonucleas
h
rnase
h
hydrolysi
critic
prime
strand
dnadepend
dna
synthesi
rausch
le
grice
splice
acceptor
site
present
sever
posit
genom
particip
product
sever
splice
viral
transcript
purcel
martin
polyadenyl
signal
use
gener
end
viral
rna
wilusz
follow
section
outlin
recent
advanc
made
small
molecul
polypeptid
oligonucleotidebas
target
cisact
element
later
section
deal
gener
issu
cellular
uptak
specif
stabil
nucleotid
terminu
viral
genom
defin
tar
hairpin
fig
whose
apic
loop
nearbi
trinucleotid
bulg
fig
serv
bind
site
viruscod
tat
protein
interact
conjunct
cellular
cofactor
transcript
elong
factorb
ptefb
significantli
enhanc
transcript
elong
karn
target
tattar
axi
interrupt
viru
life
cycl
level
transcript
consid
howev
addit
role
tar
suggest
could
also
target
affect
multipl
step
revers
transcript
sinc
tar
poli
hairpin
collect
constitut
repeat
r
region
repres
termini
strand
viral
rna
like
play
role
strand
dna
transfer
exploit
r
homolog
mutagenesi
studi
berkhout
et
al
shown
structur
featur
tar
hairpin
facilit
strand
dna
transfer
huthoff
berkhout
demonstr
mutat
region
affect
equilibrium
altern
configur
utr
design
long
distanc
base
pair
branch
conform
regul
trnaprim
initi
revers
transcript
role
tar
initi
revers
transcript
also
propos
harrich
et
al
thu
mechanist
basi
observ
requir
experiment
highlight
potenti
pleiotrop
role
tattar
axi
exploit
therapeut
view
role
highli
conserv
tar
apic
loop
transactiv
stimul
transcript
notion
disrupt
tattar
interact
steric
block
oligonucleotid
investig
arzumanov
et
al
found
sever
class
modifi
dodecamer
nucleotid
effici
antagon
tatdepend
transcript
vitro
hela
cell
nuclear
extract
arzumanov
et
al
despit
promis
result
vivo
efficaci
observ
howev
subsequ
studi
encourag
show
polyamid
nucleic
acid
analog
pna
design
interact
tar
apic
loop
adjac
bulg
nucleotid
substanti
inhibit
tatmedi
transactiv
vitro
system
transfect
cem
cell
lead
signific
drop
viru
infect
kaushik
et
al
polypeptid
analog
peptidomimet
antagon
tattar
interact
repres
altern
therapeut
strategi
although
lee
et
al
elegantli
demonstr
inhibit
replic
cell
nontox
concentr
lee
et
al
conform
flexibl
linear
polypeptid
drawback
promot
offtarget
interact
sensit
proteolysi
drawback
howev
overcom
construct
stapl
conformationallyconstrain
peptid
first
describ
mean
activ
apoptosi
target
leukemia
walenski
et
al
stapl
nativ
peptid
repres
novel
therapeut
strategi
modul
proteinprotein
interact
use
similar
strategi
varani
colleagu
lalond
et
al
design
seri
cyclic
cellperm
peptid
competit
inhibit
tattar
interact
vivo
submicromolar
concentr
minim
cytotox
surprisingli
keep
pleiotrop
natur
tattar
axi
timeofaddit
experi
indic
addit
viral
transcript
cyclic
peptid
also
act
level
revers
transcript
resist
branch
peptid
bp
ligand
proteas
peptidas
promot
use
novel
class
multival
nontox
cellperm
therapeut
featur
exploit
creat
class
peptid
bound
tar
rna
low
submicromolar
affin
bryson
et
al
like
span
nucleotid
apic
loop
neighbor
trinucleotid
bulg
although
requir
experiment
valid
potenti
therapeut
peptid
might
enhanc
design
bifunct
catalyt
inhibitor
link
target
effector
moieti
aminotermin
cu
ii
ni
ii
bind
motif
atcun
small
high
affin
metal
bind
site
locat
nterminu
mani
natur
occur
protein
shown
cleav
dna
modifi
rna
inactiv
protein
via
releas
reactiv
oxygen
speci
jin
et
al
atcun
motif
featur
three
amino
acid
sequenc
amino
acid
must
free
amino
termin
group
approach
would
requir
simpl
modif
linear
peptid
cyclic
peptid
afford
free
nterminu
append
tripeptid
lysin
side
chain
feasibl
therebi
creat
metallopeptid
capabl
target
tar
promot
nucleolyt
degrad
later
section
address
applic
metal
chelatepeptid
strategi
mean
target
rre
final
small
molecul
target
tar
hairpin
larger
part
aminoglycosid
activ
gener
suffer
lack
specif
bind
rrna
trna
sever
catalyt
rna
luedtk
et
al
blount
et
al
howev
two
recent
studi
encourag
combin
nmr
spectroscopi
comput
molecular
dynam
stelzer
et
al
taken
advantag
virtual
screen
identifi
sever
compound
antagon
tattar
interact
interact
nucleotid
apic
loop
trinucleotid
bulg
fig
stelzer
et
al
work
involv
construct
small
molecul
microarray
probe
fluorescentlylabel
rna
structur
motif
tar
apic
loop
use
approach
sztubasolinska
et
al
identifi
novel
chemotyp
fig
bind
tar
hairpin
micromolar
affin
inhibit
replic
cultur
cytotox
development
stage
small
molecul
microarray
hold
immens
potenti
target
addit
structur
motif
genom
retrovir
minu
strand
rnadepend
dna
synthesi
initi
hostcod
trna
hybrid
primer
bind
site
pb
locat
immedi
downstream
uniqu
sequenc
utr
beyond
pbsmediat
base
pair
addit
intermolecular
trnavir
rna
interact
propos
critic
mediat
initi
process
includ
interact
arich
loop
hairpin
urich
anticodon
domain
ii
nucleotid
stem
design
primer
activ
signal
pa
trna
stem
iii
nucleotid
uniqu
region
trna
anticodon
stem
abbink
berkhout
thu
steric
interfer
perspect
trnavir
rna
duplex
offer
sever
potenti
therapeut
target
exampl
abil
short
label
oligonucleotid
direct
pb
competit
inhibit
bind
vitro
replic
hela
cell
freund
et
al
curious
although
consider
bodi
literatur
avail
structur
trnavir
rna
complex
lanchi
et
al
kinet
character
trnaprim
dna
synthesi
lanchi
et
al
conform
dynam
rt
associ
event
liu
et
al
mechan
wherebi
trna
primer
incorpor
bud
virion
subsequ
hybrid
pb
recent
receiv
littl
attent
interact
human
lysyl
trna
synthetas
lysr
capsid
ca
domain
gag
precursor
via
ctermin
domain
ctd
identifi
kleiman
colleagu
whose
relat
studi
elegantli
show
disrupt
lysr
synthesi
reduc
incorpor
virion
anneal
viral
rna
genom
guo
et
al
goal
disrupt
lysrsca
interact
combinatori
librari
screen
dewan
et
al
subsequ
identifi
two
cyclic
peptid
whose
clinic
applic
take
advantag
enhanc
resist
proteolyt
degrad
activ
vitro
low
micromolar
rang
vivo
select
firstinclass
lysrsca
antagonist
demonstr
pave
way
develop
modifi
cyclic
peptid
improv
cell
penetr
pharmacokinet
properti
dimer
retrovir
genom
mediat
di
palindrom
sequenc
locat
primer
bind
encapsid
site
fig
disrupt
induc
pleiotrop
effect
sever
impair
infect
paillart
et
al
absolut
requir
cisact
signal
high
resolut
crystallograph
data
di
kiss
extend
duplex
avail
promot
construct
neamin
dimer
fig
novel
small
molecul
class
target
di
interfac
interact
rna
strand
bodlenn
et
al
vitro
analysi
confirm
compound
inde
target
di
loop
stabil
kiss
complex
although
cellular
toxic
abil
inhibit
viru
replic
remain
establish
crystallograph
data
kiss
loopaminoglycosid
complex
illustr
critic
interact
di
residu
loop
aminoglycosid
neomycin
fig
ennifar
colleagu
taken
advantag
inform
target
rna
dimer
thyminecontain
aminoglycosid
chimera
fig
capabl
hydrogen
bond
ennifar
et
al
bind
di
kiss
loop
confirm
isotherm
titrat
calorimetri
support
inabl
analog
interact
mutant
predict
disrupt
watsoncrick
base
pair
although
affin
thymineneomycin
chimera
di
moder
k
encourag
observ
abil
contrast
previou
aminoglycosid
interact
di
multipl
subtyp
without
signific
chang
affin
although
antivir
activ
remain
establish
work
provid
encourag
exampl
potenti
structurebas
drug
design
direct
develop
dimer
antagonist
improv
potenc
select
despit
extens
mutagenesi
structur
probe
effort
littl
consensu
structur
within
utr
respons
interact
dimer
viral
genom
subsequ
traffick
plasma
membran
encapsid
bud
virion
howev
landmark
nmr
studi
dimer
rna
contain
entir
utr
immedi
region
gag
provid
eleg
model
propos
ggag
tetraloop
packag
signal
defin
stemloop
sl
core
packag
domain
recogn
nc
domain
gag
precursor
rna
structur
switch
link
translat
dimer
packag
lu
et
al
fig
b
subsequ
studi
stephenson
et
al
coupl
chemic
probe
data
utr
throughspac
distanc
deriv
singl
molecul
fluoresc
reson
energi
transfer
experi
analysi
support
model
deriv
nmr
highlight
kinkturn
motif
whose
mutagenesi
previous
shown
impair
packag
suggest
may
provid
gag
bind
site
togeth
complementari
highresolut
techniqu
provid
muchneed
structur
basi
antivir
strategi
design
interrupt
genom
packag
possibl
antagon
propos
gagmedi
structur
switch
translat
viral
genom
incorpor
bud
virion
use
combin
comput
dock
high
throughput
screen
identifi
ligand
select
gnra
tetraloop
warui
et
al
identifi
sever
small
molecul
bound
rna
warui
barang
two
ligand
bound
micromolar
affin
display
enhanc
select
rna
nonspecif
singl
doublestrand
rna
disrupt
interact
nc
protein
measur
gel
electrophoret
mobil
shift
analysi
bell
et
al
design
highthroughput
fluorogen
assay
monitor
gagmedi
disrupt
rna
use
screen
two
small
molecul
librari
total
compound
bell
et
al
addit
chemotyp
previous
shown
interact
dna
author
identifi
quinolinium
deriv
fig
cultur
significantli
reduc
viru
infect
low
micromolar
rang
spectroscopi
presenc
indic
littl
influenc
stem
nucleotid
contrast
signific
perturb
nucleotid
compris
ggag
tetraloop
observ
presenc
molar
equival
ligand
indic
stoichiometri
equival
analysi
demonstr
nondiscriminatori
intercal
ellipticin
interact
exclus
nucleotid
stem
provid
promis
measur
specif
notion
import
interact
gag
viral
rna
might
target
small
molecul
infer
studi
de
guzman
et
al
shown
ggag
tetraloop
provid
tight
bind
site
nc
final
target
rna
may
restrict
small
molecul
evidenc
analysi
demonstr
short
tryptophanrich
polypeptid
propos
nc
mimic
also
interact
ggag
tetraloop
dietz
et
al
ribosom
frameshift
provid
mechan
retrovirus
frameshift
translat
control
transit
high
level
synthesi
structur
protein
encod
gag
open
read
frame
lowlevel
synthesi
enzymecontain
protein
gagpol
precursor
polyprotein
jack
et
al
frameshift
signal
group
illustr
fig
b
compris
heptanucleotid
slipperi
sequenc
follow
frameshift
stimulatori
signal
irregular
helix
whose
upper
lower
stem
separ
purin
bulg
featur
maintain
within
individu
subtyp
vari
subtyp
although
precis
mechan
underli
frameshift
remain
open
debat
maintain
correct
gag
gagpol
ratio
appear
critic
virion
assembl
matur
small
molecul
nucleic
acid
interact
frameshift
signal
alter
critic
balanc
disrupt
stabil
would
therefor
seem
attract
therapeut
strategi
high
throughput
screen
librari
chemic
entiti
hung
et
al
indic
benzen
deriv
fig
capabl
increas
frameshift
effici
approxim
twofold
impair
viru
spread
cultur
howev
shown
interact
varieti
rna
helic
suggest
toxic
issu
would
aris
consequ
preferenti
target
ribosom
rna
despit
neg
outcom
marscheschi
et
al
demonstr
nmr
spectroscopi
bind
major
groov
frameshift
signal
hydrogen
bond
phosphat
group
opposit
side
alter
conform
gga
trinucleotid
bulg
provid
import
structur
data
ration
design
deriv
increas
potenc
select
although
modif
basic
screen
strategi
dulud
et
al
yield
seri
argininerich
peptid
capabl
reduc
frameshift
effici
appear
equal
nonselect
encourag
result
report
ofori
et
al
investig
effect
nucleic
acidintercal
peptid
antibiot
ribosom
frameshift
among
benzo
g
quinolonecontain
analog
fig
bound
frameshift
site
affin
nm
increas
select
nonspecif
rna
analog
cell
permeabl
exhibit
minim
cytotox
decreas
viru
infect
correl
increas
level
frameshift
parallel
search
improv
small
molecul
ligand
potenti
oligonucleotidebas
inhibit
via
steric
block
overlook
base
studi
ahn
et
al
demonstr
pna
design
hybrid
frameshift
site
suppress
replic
sever
acut
respiratori
syndrom
coronaviru
second
class
target
three
major
stemloop
sl
domain
xrna
inhibit
rna
synthesi
initi
hepat
c
viru
ahn
et
al
earli
attempt
target
rre
respons
nucleocytoplasm
transport
unsplic
singlyspl
viral
rna
involv
small
molecul
neomycin
b
relat
aminoglycosid
outlin
earlier
suffer
lack
specif
poor
cellular
uptak
ahn
et
al
likewis
transdomin
neg
rev
mutant
promis
altern
led
rapid
acquisit
mutat
confer
resist
legiewicz
et
al
thu
new
modal
target
revrr
interact
warrant
structur
mutagenesi
analys
shown
argininerich
motif
arm
rev
mediat
critic
interact
rre
insert
major
groov
asymmetr
bulg
stemloop
iib
base
observ
mill
et
al
synthes
seri
armlik
conformationallyconstrain
peptidomimet
antagon
revrr
interact
candid
peptidomimet
examin
one
bound
rre
equival
affin
arm
k
nm
control
experi
indic
unconstrain
counterpart
show
littl
specif
target
rre
subsequ
irrevers
inactiv
reactiv
metal
chelat
append
rev
arm
propos
cowan
colleagu
strategi
develop
catalyt
metalloinhibitor
theoret
would
requir
satur
amount
achiev
maximum
potenc
bifunct
metalloinhibitor
combin
high
affin
target
motif
rev
arm
metal
chelat
complex
capabl
damag
rna
vicin
arm
bind
site
via
varieti
oxid
chemistri
proof
strategi
demonstr
abil
cuglyglyhisarm
complex
select
cleav
rre
vitro
jin
cowan
vivo
jin
cowan
approach
recent
extend
investig
oxid
properti
rev
arm
link
metal
chelat
acid
dota
diethylenetriamineepentaacet
acid
dtpa
ethylenediaminetetraacet
acid
edta
nitrilotriacet
acid
nta
joyner
cowan
fig
complex
high
affin
bind
rre
stemloop
iib
retain
vari
nm
versu
nm
unmodifi
peptid
cubound
metal
chelat
found
effici
rre
cleavag
activ
vari
order
cuntarev
cudotarev
cudtparev
cuedtarev
repres
improv
cuglyglyhisarm
complex
biolog
set
oxid
damag
rre
would
result
dissoci
metal
chelatearm
complex
reactiv
reduc
agent
ascorb
acid
glutathion
concentr
suffici
high
vivo
also
sinc
k
bound
metal
order
toxic
result
leach
complex
like
minim
branch
peptid
compris
either
natur
unnatur
amino
acid
combin
thereof
gain
attent
therapeut
agent
base
potenti
multival
target
rna
well
resist
proteolysi
bryson
et
al
high
throughput
screen
branch
peptid
boron
acid
bpba
librari
whose
boron
acid
substitu
design
mimic
acceptor
rna
oh
group
well
improv
select
rna
dna
identifi
candid
peptid
bound
rre
stemloop
iib
micromolar
affin
zhang
et
al
stoichiometri
signific
loss
bind
affin
linear
peptid
suggest
arm
branch
peptid
particip
interact
stemloop
iib
complementari
analysi
stemloop
iib
variant
provid
strong
support
notion
correct
tertiari
structur
target
rna
prerequisit
high
affin
bind
consist
find
enzymat
footprint
highlight
sever
region
stemloop
iib
render
nucleaseinsensit
presenc
branch
peptid
final
studi
fluoresc
deriv
suggest
taken
cell
although
abil
suppress
replic
remain
establish
lastli
avail
high
resolut
structur
rre
twodimension
level
compris
collect
hairpin
loop
bulg
promot
novel
strategi
target
addit
uniqu
pocket
site
either
small
molecul
macromolecul
therapeut
respect
recent
effort
provid
work
model
rre
fig
lusvarghi
et
al
subsequ
fig
fang
et
al
illustr
fig
although
structur
organ
individu
domain
may
differ
rre
appear
assum
unusu
alik
topolog
rre
leg
structur
whose
separ
propos
necessari
rre
function
suggest
constitut
bind
track
cooper
bind
rev
structur
hope
serv
target
new
gener
molecular
scaffold
hiv
strand
dna
synthesi
initi
terminu
polypurin
tract
ppt
locat
adjac
region
ltr
center
genom
cppt
role
cppt
somewhat
controversi
mutat
studi
hu
et
al
rais
intrigu
notion
perhap
conjunct
central
termin
sequenc
ct
cppt
less
relev
nuclear
import
minim
exposur
unpair
strand
dna
host
restrict
factor
famili
apobec
protein
issu
notwithstand
accur
select
cppt
primer
rnadna
replic
intermedi
remov
nascent
strand
dna
repres
critic
step
viral
replic
cycl
despit
extens
mutagenesi
analysi
rausch
le
grice
structur
basi
resist
pptcontain
rnadna
hybrid
rnase
hmediat
cleavag
remain
unclear
howev
structur
studi
combin
mass
spectrometri
nmr
turner
et
al
rais
possibl
ppt
could
target
small
molecul
design
antagon
select
remov
nascent
dna
electrospray
ionizationfouri
transfer
ion
cyclotron
reson
mass
spectrometri
particular
advantag
allow
multiplex
ie
interact
nucleic
acid
ligand
sever
ppt
variant
could
simultan
investig
base
mass
signatur
use
approach
turner
et
al
show
short
pptcontain
rnadna
hybrid
contain
two
bind
site
aminoglycosid
neomycin
b
turner
et
al
tandem
mass
spectrometri
essenti
provid
footprint
pptneomycin
b
complex
demonstr
neomycin
b
ppt
ratio
aminoglycosid
bound
junction
increas
ratio
identifi
second
upstream
aminoglycosid
bind
site
extrem
ppt
fig
consist
observ
neomycin
b
ppt
hybrid
show
shift
imino
proton
signal
posit
correspond
junction
evid
second
bind
site
ratio
increas
subsequ
nmr
analysi
presenc
rt
indic
contact
protein
nucleic
acid
two
region
equival
find
rt
ltrretrotransposon
cognat
ppt
brinson
et
al
suggest
structur
featur
either
extrem
ppt
may
gener
featur
contribut
recognit
data
intend
impli
therapeut
use
neomycin
b
known
bind
varieti
rna
structur
rather
illustr
select
nucleic
acid
ligand
could
develop
disrupt
strand
dna
synthesi
intrigu
mean
hiv
ppt
might
target
context
singlestrand
rna
genom
rnadna
intermedi
integr
doublestrand
dna
involv
use
triplex
form
oligonucleotid
tfo
bind
oligopurin
strand
duplex
hoogsteen
revers
hoogsteen
hydrogen
bond
studi
volkmann
moell
demonstr
vitro
tfo
target
ppt
render
junction
refractori
rnase
hmediat
hydrolysi
consequ
inhibit
initi
strand
dna
synthesi
volkmann
et
al
order
determin
whether
ppt
sequenc
singlestrand
viral
rna
genom
rnadna
replic
intermedi
might
also
respond
triplex
format
author
target
singlestrand
ppt
tfo
wherein
watsoncrick
hoogsteen
base
pair
sequenc
strand
separ
short
linker
sequenc
sandwich
tfo
suggest
thermodynam
effici
threestrand
system
also
render
ppt
refractori
rnase
hmediat
cleavag
vitro
inhibit
de
novo
hiv
infect
cultur
final
although
hiv
rna
genom
focu
review
worth
note
giovannang
et
al
use
tfo
approach
target
ppt
context
integr
provir
dna
use
tfopsoralen
conjug
author
success
convert
noncoval
threestrand
structur
local
coval
lesion
genom
dna
follow
uv
irradi
cell
giovannang
et
al
concept
target
hiv
rna
genom
small
molecul
peptid
oligonucleotid
gain
popular
abil
penetr
cell
membran
peptid
nucleic
acid
access
target
without
initi
immun
respons
present
signific
challeng
promis
advanc
area
develop
short
cellpenetr
peptid
cpp
compris
combin
natur
unnatur
amino
acid
basi
origin
observ
tat
could
enter
cell
ad
cultur
medium
addit
argininerich
tat
peptid
natur
cpp
identifi
includ
penetratin
herpesviru
tegument
protein
mycobacterium
tuberculosi
capac
promot
intracellular
uptak
conjug
cargo
copolovici
et
al
proofofprincipl
roisin
et
al
shown
tatderiv
cpp
link
peptid
ligand
antagon
interact
rev
cellular
factor
critic
nucleocytoplasm
rna
transport
inhibit
replic
primari
lymphocyt
macrophag
although
applic
steric
block
spliceswitch
oligonucleotid
antagonist
hiv
replic
limit
cppconjug
oligonucleotid
retain
attract
therapeut
agent
oligonucleotid
contain
peptid
nucleic
acid
pna
lock
nucleic
acid
lna
phosphorodiamid
morpholino
pmo
analog
commonli
use
order
avoid
complic
aris
interact
neg
charg
nucleic
acid
posit
charg
cpp
follow
uptak
endosom
releas
cppoligonucleotid
complex
present
next
challeng
inhibitori
cpppna
conjug
target
tar
hairpin
could
releas
endosom
chloroquin
treatment
clinic
impract
demonstr
endosom
releas
rate
limit
step
turner
et
al
altern
strategi
promot
endosom
releas
includ
identif
cpp
elicit
endosomolyt
activ
cpp
modif
via
stearyl
myristoyl
incorpor
chloroquinefunction
dendron
backbon
comprehens
review
cppdirect
oligonucleotid
deliveri
challeng
futur
potenti
found
lee
et
al
final
efficaci
small
molecul
target
cisact
sequenc
rna
genom
might
current
limit
due
poor
cellular
uptak
cppmediat
deliveri
doxorubicin
methotrex
paclitaxel
stewart
et
al
provid
encourag
evid
exploit
novel
technolog
although
develop
cure
hiv
desir
goal
achiev
antivir
therapi
remain
mainstay
inhibit
viru
replic
spread
aid
respect
viral
rna
genom
technolog
advanc
provid
first
glimps
complet
genom
structur
highlight
complex
collect
inter
intramolecular
interact
critic
mediat
replic
well
nucleocytoplasm
transport
translat
dimer
packag
mani
complex
dissect
atom
level
varieti
biophys
approach
includ
xray
crystallographi
nmr
spectroscopi
small
angl
xray
scatter
cryoem
tomographi
success
collect
provid
us
wealth
interact
antagon
disrupt
hiv
replic
form
small
molecul
peptid
therapeut
rna
develop
novel
costeffect
fluorescencebas
highthroughput
screen
methodolog
recapitul
interact
encourag
acceler
assault
rna
genom
complement
ongo
effort
target
rna
treatment
multitud
diseas
state
